Sanofi's Strategic Shift: Spinning Off Consumer Unit and Focusing on R&D
TL;DR Summary
Sanofi plans to spin out its consumer health unit and allocate €2 billion ($2.1 billion) in savings towards research and development efforts. The move is part of the company's strategy to focus on bringing the next wave of medical advances to market, following the trend set by other large drugmakers. The cuts will take place between 2024 and 2025, with the consumer unit likely becoming an independent French company by the end of next year.
- Sanofi will spin out consumer unit, putting weight behind R&D efforts: 'I have to invest in the science now' Endpoints News
- Sanofi shares plunge after 2025 target dropped, consumer unit marked for spin-off Reuters
- Sanofi Shares Plunge After Earnings Fall Short of Estimates Bloomberg
- Sanofi shares sink on lower profit outlook and consumer unit split Financial Times
- Sanofi to create its own Haleon, Kenvue as its stock price tumbles Invezz
- View Full Coverage on Google News
Reading Insights
Total Reads
0
Unique Readers
2
Time Saved
0 min
vs 1 min read
Condensed
45%
137 → 75 words
Want the full story? Read the original article
Read on Endpoints News